Cybele Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 6, 2025, 12:22 am

Quick Insight

Cybele Industries Ltd, operating in the Cables – Power/Others industry, currently trades at a price of 25.4 with a market capitalization of 27.2 Cr. The company's Return on Equity (ROE) stands at a healthy 22.1%, while Return on Capital Employed (ROCE) is at 13.5%. However, the Operating Profit Margin (OPM) is notably low at -42.31%, resulting in a Net Profit of -12 Cr. The company's low Price-to-Book Value (P/BV) ratio of 0.43x and negative Interest Coverage Ratio (ICR) of -8.90x raise concerns about its financial health. With reserves of 37 Cr and borrowings of ₹26 Cr, Cybele Industries faces a challenging Cash Conversion Cycle (CCC) of 126.04 days. In conclusion, while the company demonstrates strong ROE and ROCE figures, its negative profitability indicators and weak financial ratios warrant a closer examination of its operational efficiency and debt management strategies.

Competitors of Cybele Industries Ltd

All Competitor Stocks of Cybele Industries Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:35 pm

Below is a detailed analysis of the quarterly data for Cybele Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3.90 Cr.. The value appears to be declining and may need further review. It has decreased from 8.40 Cr. (Mar 2025) to 3.90 Cr., marking a decrease of 4.50 Cr..
• For Expenses, as of Jun 2025, the value is 5.55 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.84 Cr. (Mar 2025) to 5.55 Cr., marking a decrease of 3.29 Cr..
• For Operating Profit, as of Jun 2025, the value is -1.65 Cr.. The value appears to be declining and may need further review. It has decreased from -0.44 Cr. (Mar 2025) to -1.65 Cr., marking a decrease of 1.21 Cr..
• For OPM %, as of Jun 2025, the value is -42.31%. The value appears to be declining and may need further review. It has decreased from -5.24% (Mar 2025) to -42.31%, marking a decrease of 37.07%.
• For Other Income, as of Jun 2025, the value is 9.87 Cr.. The value appears strong and on an upward trend. It has increased from 0.05 Cr. (Mar 2025) to 9.87 Cr., marking an increase of 9.82 Cr..
• For Interest, as of Jun 2025, the value is 0.42 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.49 Cr. (Mar 2025) to 0.42 Cr., marking a decrease of 0.07 Cr..
• For Depreciation, as of Jun 2025, the value is 0.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.12 Cr. (Mar 2025) to 0.26 Cr., marking an increase of 0.14 Cr..
• For Profit before tax, as of Jun 2025, the value is 7.54 Cr.. The value appears strong and on an upward trend. It has increased from -1.00 Cr. (Mar 2025) to 7.54 Cr., marking an increase of 8.54 Cr..
• For Tax %, as of Jun 2025, the value is -0.40%. The value appears to be improving (decreasing) as expected. It has decreased from 0.00% (Mar 2025) to -0.40%, marking a decrease of 0.40%.
• For Net Profit, as of Jun 2025, the value is 7.57 Cr.. The value appears strong and on an upward trend. It has increased from -0.99 Cr. (Mar 2025) to 7.57 Cr., marking an increase of 8.56 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.08. The value appears strong and on an upward trend. It has increased from -0.93 (Mar 2025) to 7.08, marking an increase of 8.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:01 pm

Growth

Last Updated: September 5, 2025, 3:06 pm

Balance Sheet

Last Updated: July 25, 2025, 1:30 pm

Below is a detailed analysis of the balance sheet data for Cybele Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Mar 2024) to 37.00 Cr., marking a decrease of 12.00 Cr..
• For Borrowings, as of Mar 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 19.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 7.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 77.00 Cr.. The value appears to be improving (decreasing). It has decreased from 82.00 Cr. (Mar 2024) to 77.00 Cr., marking a decrease of 5.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 61.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 61.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Mar 2024) to 16.00 Cr., marking a decrease of 5.00 Cr..
• For Total Assets, as of Mar 2025, the value is 77.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Mar 2024) to 77.00 Cr., marking a decrease of 5.00 Cr..

Notably, the Reserves (37.00 Cr.) exceed the Borrowings (26.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

No data available for the No. of Shareholders chart.

Key Financial Ratios

After reviewing the key financial ratios for Cybele Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -12.72. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to -12.72, marking a decrease of 12.77.
• For Diluted EPS (Rs.), as of Mar 25, the value is -12.72. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to -12.72, marking a decrease of 12.77.
• For Cash EPS (Rs.), as of Mar 25, the value is -12.27. This value is below the healthy minimum of 3. It has decreased from 0.67 (Mar 24) to -12.27, marking a decrease of 12.94.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 42.81. It has decreased from 55.53 (Mar 24) to 42.81, marking a decrease of 12.72.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 42.81. It has decreased from 55.53 (Mar 24) to 42.81, marking a decrease of 12.72.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.10. It has decreased from 33.17 (Mar 24) to 19.10, marking a decrease of 14.07.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -10.81. This value is below the healthy minimum of 2. It has decreased from 1.63 (Mar 24) to -10.81, marking a decrease of 12.44.
• For PBIT / Share (Rs.), as of Mar 25, the value is -11.26. This value is below the healthy minimum of 0. It has decreased from 0.88 (Mar 24) to -11.26, marking a decrease of 12.14.
• For PBT / Share (Rs.), as of Mar 25, the value is -12.47. This value is below the healthy minimum of 0. It has decreased from -0.25 (Mar 24) to -12.47, marking a decrease of 12.22.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -12.72. This value is below the healthy minimum of 2. It has decreased from -0.06 (Mar 24) to -12.72, marking a decrease of 12.66.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -12.72. This value is below the healthy minimum of 2. It has decreased from -0.06 (Mar 24) to -12.72, marking a decrease of 12.66.
• For PBDIT Margin (%), as of Mar 25, the value is -56.58. This value is below the healthy minimum of 10. It has decreased from 4.89 (Mar 24) to -56.58, marking a decrease of 61.47.
• For PBIT Margin (%), as of Mar 25, the value is -58.93. This value is below the healthy minimum of 10. It has decreased from 2.67 (Mar 24) to -58.93, marking a decrease of 61.60.
• For PBT Margin (%), as of Mar 25, the value is -65.28. This value is below the healthy minimum of 10. It has decreased from -0.76 (Mar 24) to -65.28, marking a decrease of 64.52.
• For Net Profit Margin (%), as of Mar 25, the value is -66.57. This value is below the healthy minimum of 5. It has decreased from -0.20 (Mar 24) to -66.57, marking a decrease of 66.37.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -66.57. This value is below the healthy minimum of 8. It has decreased from -0.20 (Mar 24) to -66.57, marking a decrease of 66.37.
• For Return on Networth / Equity (%), as of Mar 25, the value is -29.70. This value is below the healthy minimum of 15. It has decreased from -0.12 (Mar 24) to -29.70, marking a decrease of 29.58.
• For Return on Capital Employeed (%), as of Mar 25, the value is -16.46. This value is below the healthy minimum of 10. It has decreased from 1.41 (Mar 24) to -16.46, marking a decrease of 17.87.
• For Return On Assets (%), as of Mar 25, the value is -17.44. This value is below the healthy minimum of 5. It has decreased from -0.08 (Mar 24) to -17.44, marking a decrease of 17.36.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.57. This value is within the healthy range. It has increased from 0.11 (Mar 24) to 0.57, marking an increase of 0.46.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.61. This value is within the healthy range. It has increased from 0.31 (Mar 24) to 0.61, marking an increase of 0.30.
• For Current Ratio (X), as of Mar 25, the value is 2.30. This value is within the healthy range. It has increased from 1.03 (Mar 24) to 2.30, marking an increase of 1.27.
• For Quick Ratio (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has increased from 0.45 (Mar 24) to 1.23, marking an increase of 0.78.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -8.90. This value is below the healthy minimum of 3. It has decreased from 1.43 (Mar 24) to -8.90, marking a decrease of 10.33.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -9.48. This value is below the healthy minimum of 3. It has decreased from 0.94 (Mar 24) to -9.48, marking a decrease of 10.42.
• For Enterprise Value (Cr.), as of Mar 25, the value is 46.68. It has decreased from 58.19 (Mar 24) to 46.68, marking a decrease of 11.51.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.28. This value is within the healthy range. It has increased from 1.64 (Mar 24) to 2.28, marking an increase of 0.64.
• For EV / EBITDA (X), as of Mar 25, the value is -4.04. This value is below the healthy minimum of 5. It has decreased from 33.47 (Mar 24) to -4.04, marking a decrease of 37.51.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.96, marking a decrease of 0.16.
• For Price / BV (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.66 (Mar 24) to 0.43, marking a decrease of 0.23.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.96, marking a decrease of 0.16.
• For EarningsYield, as of Mar 25, the value is -0.68. This value is below the healthy minimum of 5. It has decreased from 0.00 (Mar 24) to -0.68, marking a decrease of 0.68.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness